Skip to main content
SpringerLink
Log in
Book cover

Kidney Cancer pp 199–212Cite as

Monoclonal Antibody Therapy of Kidney Cancer

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 116))

Abstract

There is a clear need for effective treatment of metastasized Renal Cell Carcinoma (RCC): despite intensive efforts to develop an effective treatment, once RCC has metastasized, treatment options are very limited. This tumor is not radiosensitive, resistant to chemotherapy, and treatment with biological response modifiers (IL-2, IFN) leads to low response rates.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amato, RJ. Chemotherapy for renal cell carcinoma. Semin. Oncol., 27: 177–186,2000.

    PubMed  CAS  Google Scholar 

  2. Bander, NH, Cordon-Cardo, C, Finstad, CL, Whitmore, WF, Jr, Vaughan, ED, Jr, Oettgen, HF, Melamed, M, and Old, LJ. Immunohistologic dissection of the human kidney using monoclonal antibodies. J. Urol., 133: 502–505,1985.

    PubMed  CAS  Google Scholar 

  3. Bander, NH, Finstad, CL, Cordon-Cardo, C, Ramsawak, RD, Vaughan, ED, Jr, Whitmore, WF, Jr, Oettgen, HF, Melamed, MR, and Old, LJ. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res., 49: 6774–6780,1989.

    PubMed  CAS  Google Scholar 

  4. Baxter, LT, and Jain, RK. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res., 37: 77–104,1989.

    CAS  Google Scholar 

  5. Bernhard, H, Maeurer, MJ, Jager, E, Wolfel, T, Schneider, J, Karbach, J, Seliger, B, Huber, C, Storkus, WS, Lotze, MT, Meyer zum Buschenfelde, KH, and Knuth, A. Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma. Scand. J. Immunol., 44: 285–292,1996.

    CAS  Google Scholar 

  6. Boon, T, Coulie, PG, and Van den, EB. Tumor antigens recognized by T cells. Immunol. Today, 18: 267–268,1997.

    Article  PubMed  CAS  Google Scholar 

  7. Brouwenstijn, N, Hoogstraten, C, Verdegaal, EM, Van der Spek,CW, Deckers, JG, Mulder, A, Osanto, S, and Schrier, PI. Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma. J. Immunother., 21: 427–434,1998.

    Article  PubMed  CAS  Google Scholar 

  8. Chiou, RK. Biodistribution and radioimmunoscintigraphy studies of renal cell carcinoma using tumor-preferential monoclonal antibodies and F(ab’)2 fragments. J. Urol., 142: 1584–1588,1989.

    PubMed  CAS  Google Scholar 

  9. Divgi, CR, Bander, NH, Scott, AM, O’Donoghue, JA, Sgouros, G, Welt, S, Finn, RD, Morrissey, F, Capitelli, P, Williams, JM, Deland, D, Nakhre, A, Oosterwijk, E, Gulec, S, Graham, MC, Larson, SM, and Old,LJ. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin. Cancer Res, 4: 2729–2739,1998.

    CAS  Google Scholar 

  10. Ehrlich, P. On immunity with special reference to cell life. In: the collected papers of Paul Ehrlich, volume II:Immunology and Cancer Research. Himmelweit F, Marquardt M, Dale H (Eds). Pergamon Press, London. 1957. Ref Type: Generic.

    Google Scholar 

  11. Elhilali, MM, Gleave, M, Fradet,Y, Davis, I, Venner, P, Saad, F, Klotz, L, Moore, R, Ernst, S, and Paton, V. Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1 b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group. BJU. Int, 86: 613–618,2000.

    Article  PubMed  CAS  Google Scholar 

  12. Finke, JH, Rayman, P, Alexander, J, Edinger, M, Tubbs, RR, Connelly, R, Pontes, E, and Bukowski, R. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Cancer Res, 50: 2363–2370,1990.

    PubMed  CAS  Google Scholar 

  13. Finke, JH, Rayman, P, Edinger, M, Tubbs, RR, Stanley, J, Klein, E, and Bukowski, R. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line. J. Immunother., 11: 1–11, 1992.

    Article  PubMed  CAS  Google Scholar 

  14. Finstad, CL, Cordon-Cardo, C, Bander, NH, Whitmore, WF, Melamed, MR, and Old, LJ. Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc. Natl. Acad. Sci. U.S.A, 82: 2955–2959,1985.

    Article  PubMed  CAS  Google Scholar 

  15. Fischer, P, Storkel, S, Haase, W, and Scherberich, JE. Differential diagnosis of histogenetically distinct human epithelial renal tumours with a monoclonal antibody against gamma-glutamyltransferase. Cancer Immunol. Immunother., 33: 382–388,1991.

    Article  PubMed  CAS  Google Scholar 

  16. Gaugler, B, Brouwenstijn, N, Vantomme, V, Szikora, JP, Van der Spek, CW, Patard, JJ, Boon, T, Schrier, P, and Van den Eynde, BJ. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics, 44: 323–330, 1996.

    Article  PubMed  CAS  Google Scholar 

  17. Grabmaier, K, Vissers, JL, De Weijert, MC, Oosterwijk-Wakka, JC, Van Bokhoven, A, Brakenhoff, RH, Noessner, E, Mulders, PA, Merkx, G, Figdor, CG, Adema, GJ, and Oosterwijk, E. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int. J. Cancer, 85: 865–870, 2000.

    Article  PubMed  CAS  Google Scholar 

  18. Jain, RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res., 50: 814s-819s, 1990.

    PubMed  CAS  Google Scholar 

  19. Jain, RK, and Baxter, LT. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res., 48: 7022–7032, 1988.

    PubMed  CAS  Google Scholar 

  20. Jungbluth, AA, Busam, KJ, Kolb, D, Iversen, K, Coplan, K, Chen, YT, Spagnoli, GC, and Old, U. Expression of MAGE-antigens in normal tissues and cancer. Int. J. Cancer, 85: 460–465, 2000.

    Article  PubMed  CAS  Google Scholar 

  21. Jungbluth, AA, Stockert, E, Chen, YT, Kolb, D, Iversen, K, Coplan, K, Williamson, B, Altorki, N, Busam, KJ, and Old, LJ. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br. J. Cancer, 83: 493–497, 2000.

    Article  PubMed  CAS  Google Scholar 

  22. Kinouchi, T, Nakayama, E, Ueda, R, Ishiguro, S, Uenaka, A, Oda, H, and Kotake, T. Characterization of a kidney antigen defined by a mouse monoclonal antibody K2.7. J. Urol., 137: 151–154, 1987.

    PubMed  CAS  Google Scholar 

  23. Kohler, G, and Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256: 495–497, 1975.

    Article  PubMed  CAS  Google Scholar 

  24. Kranenborg, MH, Boerman, OC, De Weijert, MC, Oosterwijk-Wakka, JC, Corstens, FH, and Oosterwijk, E. The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts. Cancer, 80: 2390–2397, 1997.

    Article  PubMed  CAS  Google Scholar 

  25. Liu, Z, Smyth, FE, Renner, C, Lee, FT, Oosterwijk, E, and Scott, AM. Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother., 51: 171–177, 2002.

    Article  PubMed  CAS  Google Scholar 

  26. Nishiyama, K, Shirahama, T, Yoshimura, A, Sumizawa, T, Furukawa, T, Ichikawa-Haraguchi, M, Akiyama, S, and Ohi,Y. Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas. Cancer, 71: 3611–3619, 1993.

    Article  PubMed  CAS  Google Scholar 

  27. Oosterwijk, E, Bander, NH, Divgi, CR, Welt, S, Wakka, JC, Finn, RD, Carswell, EA, Larson, SM, Warnaar, SO, Fleuren, GJ, Oettgen, HF, and Old, LJ Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J. Clin. Oncol., 11: 738–750, 1993.

    PubMed  CAS  Google Scholar 

  28. Oosterwijk, E, Ruiter, DJ, Hoedemaeker, PJ, Pauwels, EK, Jonas, U, Zwartendijk, J, and Warnaar, SO. Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int. J. Cancer, 38: 489–494, 1986.

    Article  PubMed  CAS  Google Scholar 

  29. Oosterwijk, E, Ruiter, DJ, Wakka, JC, Huiskens-van der Meij JW, Jonas, U, Fleuren, GJ, Zwartendijk, J, Hoedemaeker, P, and Warnaar, SO. Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am. J. Pathol., 123: 301–309, 1986.

    PubMed  CAS  Google Scholar 

  30. Rachel, U, Baum, RP, Fischer, P, Jonas, D, and Scherberich, JE. Monoclonal antibody 138H11 in immunoscintigraphy of human kidney tumors-in vitro results. Investig. Urol. (Berl), 5:66–68, 66–68, 1994.

    CAS  Google Scholar 

  31. Scanlan, MJ, Altorki, NK, Gure, AO, Williamson, B, Jungbluth, A, Chen,YT, and Old, LJ. Expression of cancer-testis antigens in lung cancer: defmition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett., 150: 155–164, 2000.

    Article  PubMed  CAS  Google Scholar 

  32. Schaub, TP, Kartenbeck, J, Konig, J, Spring, H, Dorsam, J, Staehler, G, Storkel, S, Thon, WF, and Keppler, D. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J. Am. Soc. Nephrol., 10: 1159–1169, 1999.

    PubMed  CAS  Google Scholar 

  33. Schendel, DJ, Gansbacher, B, Oberneder, R, Kriegmair, M, Hofstetter, A, Riethmuller, G, and Segurado, OG. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol., 151: 4209–4220, 1993.

    PubMed  CAS  Google Scholar 

  34. Steffens, MG, Boerman, OC, de Mulder, PH, Oyen, WJ, Buijs, WC, Wides, JA, van den Broek, WJ, Oosterwijk-Wakka, JC, Debruyne, FM, Corstens, FH, and Oosterwijk, E. Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. Clin. Cancer Res., 5: 3268s-3274s, 1999.

    PubMed  CAS  Google Scholar 

  35. Steffens, MG, Boerman, OC, Oosterwijk-Wakka, JC, Oosterhof, GO, Witjes, JA, Koenders, EB, Oyen, WJ, Buijs, WC, Debruyne, FM, Corstens, FH, and Oosterwijk, E. Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. J. Clin. Oncol., 15: 1529–1537,1997.

    PubMed  CAS  Google Scholar 

  36. Steffens, MG, Boerman, OC, Oyen, WJ, Kniest, PH, Wides, JA, Oosterhof, GO, van Leenders, GJ, Debruyne, FM, Corstens, FH, and Oosterwijk, E. Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy. Cancer Res., 59: 1615–1619,1999.

    PubMed  CAS  Google Scholar 

  37. Steffens, MG, Kranenborg, MH, Boerman, OC, Zegwaart-Hagemeier, NE, Debruyne, FM, Corstens, FH, and Oosterwijk, E. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts. Cancer Biother. Radiopharm., 13: 133–139,1998.

    Article  PubMed  CAS  Google Scholar 

  38. Steffens, MG, Oosterwijk-Wakka, JC, Zegwaart-Hagemeier, NE, Boerman, OC, Debruyne, FM, Corstens, FH, and Oosterwijk, E Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250. Anticancer Res., 19: 1197–1200,1999.

    PubMed  CAS  Google Scholar 

  39. Surfus, JE, Hank, JA, Oosterwijk, E, Welt, S, Lindstrom, MJ, Albertini, MR, Schiller, JH, and Sondel, PM. Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors. J. Immunother. Emphasis. Tumor Immunol., 19: 184–191,1996.

    Article  PubMed  CAS  Google Scholar 

  40. Tokuyama, H, and Tokuyama,Y. Mouse monoclonal antibodies with restricted specificity for human renal cell carcinoma and ability to modulate the tumor cell growth in vitro. Hybridoma, 7: 155–165, 1988.

    Article  PubMed  CAS  Google Scholar 

  41. Ueda, R, Shiku, H, Pfreundschuh, M, Takahashi, T, Li, LT, Whitmore, WF, Oettgen, HF, and Old, LJ. Cell surface antigens of human renal cancer defined by autologous typing. J. Exp. Med., 150: 564–579,1979.

    Article  PubMed  CAS  Google Scholar 

  42. Uemura, H, Nakagawa, Y, Yoshida, K, Saga, S, Yoshikawa, K, Hirao, Y, and Oosterwijk, E. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br. J. Cancer, 81: 741–746, 1999.

    Article  PubMed  CAS  Google Scholar 

  43. van Dijk, J, Oosterwijk, E, van Kroonenburgh, MJ, Jonas, U, Fleuren, GJ, Pauwels, EK, and Warnaar, SO. Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodies. J. Nucl. Med., 29: 1078–1082,1988.

    PubMed  Google Scholar 

  44. van Dijk, J, Uemura, H, Beniers, AJ, Peelen, WP, Zegveld, ST, Fleuren, GJ, Warnaar, SO, and Oosterwijk, E. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts. Int. J. Cancer, 56: 262–268,1994.

    Article  PubMed  Google Scholar 

  45. van Dijk, J, Zegveld, ST, Fleuren, GJ, and Warnaar, SO. Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity. Int. J. Cancer, 48: 738–743,1991.

    Article  PubMed  Google Scholar 

  46. Vessella, RL, Lange, PH, Palme, DF, Chiou, RK, Elson, MK, and Wessels, BW. Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice. Targeted Diagn. Ther., 1:245–282.: 245–282,1988.

    CAS  Google Scholar 

  47. Vessella, RL, Moon, TD, Chiou, RK, Nowak, JA, Arfman, EW, Palme, DF, Peterson, GA, and Lange, PH. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens. Cancer Res., 45: 6131–6139,1985.

    PubMed  CAS  Google Scholar 

  48. Welt, S, Divgi, CR, Real, FX, Yeh, SD, Garin-Chesa, P, Finstad, CL, Sakamoto, J, Cohen, A, Sigurdson, ER, Kemeny, N, and. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. J. Clin. Oncol., 8: 1894–1906,1990.

    PubMed  CAS  Google Scholar 

  49. Yoshida, SO, and Imam, A. Monoclonal antibody to a proximal nephrogenic renal antigen-immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas. Cancer Res., 49: 1802–1809,1989.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Medical Center Nijmegen, Nijmegen, The Netherlands

    Egbert Oosterwijk PH.D. & Peter Mulders M.D.

  2. Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands

    Adrienne Brouwers M.D. & OTTO C. Boerman PH.D.

  3. Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, U.S.A.

    Steven M. Larson M.D. & Chaitanya R. Divgi M.D.

  4. Ludwig Institute for Cancer Research, New York, U.S.A

    Lloyd J. Old M.D.

Authors
  1. Egbert Oosterwijk PH.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrienne Brouwers M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. OTTO C. Boerman PH.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven M. Larson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lloyd J. Old M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Mulders M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chaitanya R. Divgi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, Los Angeles, CA, USA

    Robert A. Figlin

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Oosterwijk, E. et al. (2003). Monoclonal Antibody Therapy of Kidney Cancer. In: Figlin, R.A. (eds) Kidney Cancer. Cancer Treatment and Research, vol 116. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0451-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0451-1_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5083-5

  • Online ISBN: 978-1-4615-0451-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation